Skip to content
PatentBrief

Life Sciences Patents

Precision Fermentation Patents

Microbial protein, alternative dairy, and mycoprotein fermentation IP; precision fermentation patent landscape for alternative protein startups.

FAQ

Who are the major precision fermentation patent holders and what innovations do Perfect Day, Remilk, and Quorn protect?

Precision fermentation patents cover microbial expression system and host organism innovations; bioreactor fermentation process and titer yield optimization innovations; downstream processing purification and formulation innovations; and food-grade protein characterization and functionality innovations — with IP held by alternative protein companies, food ingredient conglomerates, and agricultural biotech companies: MAJOR PRECISION FERMENTATION PATENT HOLDERS: PERFECT DAY: 200+; specific whey protein innovations (specific specific β-lactoglobulin BLG: specific specific Trichoderma reesei filamentous fungus host from specific specific fed-batch 50,000 L industrial scale from specific specific 6% protein titer by dry weight from specific specific 24-hour fermentation cycle from specific specific GRAS generally recognized as safe FDA from specific specific non-animal whey protein milk equivalent from specific specific 99% same as bovine BLG sequence from specific specific deproteinization centrifuge UF/DF ultrafiltration from specific specific diafiltration UF/DF 3-5× diafiltration volumes from specific specific spray drying 150°C inlet from specific specific Perfect Day Flora brand from specific specific Nick 100% animal-free ice cream from specific specific BASF Cargill distribution from specific specific $250M raised 2021); REMILK: 100+; specific yeast innovations (specific specific BLG Pichia pastoris methylotrophic yeast from specific specific GS115 strain AOX1 promoter from specific specific methanol induction 0.5-1% v/v from specific specific 100 g/L titer 150 hr fermentation from specific specific exceeds bovine milk BLG 3.2 g/L from specific specific Israel FDA GRAS 2022 from specific specific partnership ADM); NOBELL FOODS: 100+; MOTIF FOODWORKS: 100+; QUORN/MARLOW FOODS: 200+.

What microbial expression system, bioreactor process, and downstream purification innovations are patentable?

Filamentous fungus and yeast expression vector and promoter engineering innovations; fed-batch and continuous fermentation process control and yield optimization innovations; and membrane ultrafiltration chromatography spray drying downstream purification innovations represent core precision fermentation patent domains: MICROBIAL EXPRESSION SYSTEM PATENTS: PERFECT DAY; REMILK; NOBELL; GINKGO: specific expression innovations (specific specific Trichoderma reesei: specific specific cbh1 cbh2 cel7A cellobiohydrolase secretion signal from specific specific glucoamylase cbh1 promoter strong from specific specific CRISPR KO cellulase cbh1 cbh2 EG1 for product purity from specific specific 150 g/L protein productivity from specific specific Pichia pastoris: specific specific pAOX1 methanol-inducible promoter from specific specific pGAP constitutive promoter from specific specific alpha mating factor pre-pro secretion from specific specific 100 g/L BLG Remilk from specific specific Saccharomyces cerevisiae: specific specific GAL1 galactose-inducible from specific specific SEC pathway secretion from specific specific FLO aggregation-based cell retention from specific specific E. coli: specific specific T7 lac promoter inclusion body from specific specific refolding urea 8M GuHCl from specific specific CHO Chinese hamster ovary: specific specific CMV promoter stable integrant from specific specific fed-batch 10 g/L IgG production from specific specific Aspergillus niger: specific specific glaA glucoamylase strong promoter from specific specific CRISPR Cas9 protease KO pyrG selection from specific specific codon optimization: specific specific preferred codon GC% adjustment from specific specific CAI codon adaptation index from specific specific gene synthesis IDT Twist 200-nt oligopool); BIOREACTOR PROCESS PATENTS: GINKGO; DSM; EVONIK; NOVOZYMES: specific bioreactor innovations (specific specific fed-batch process: specific specific DO dissolved oxygen cascade glucose feed from specific specific exponential μ 0.1-0.3 h⁻¹ from specific specific pCO₂ control <100 mbar from specific specific specific carbon feed glucose sucrose from specific specific foam control polypropylene glycol from specific specific perfusion continuous: specific specific ATF alternating tangential flow from specific specific bleed 0.5-1 VVD from specific specific >10⁷ cells/mL from specific specific productivity 2-5 g/L/day from specific specific airlift bioreactor mycoprotein: specific specific Quorn Fusarium venenatum 50 m³ airlift from specific specific 25°C 5.7 pH aeration 0.5-1 VVM from specific specific 60 g/L mycoprotein 40% dry weight from specific specific quench 90°C 30 min RNA reduction from specific specific RNA <1% FDA limit from specific specific OUR oxygen uptake rate 50 mmol/L/hr from specific specific CER carbon evolution rate RQ=1.05); DOWNSTREAM PATENTS: PERFECT DAY; REMILK; DSM; KEMIN: specific downstream innovations (specific specific ultrafiltration UF: specific specific 10 kDa MWCO polyethersulfone membrane from specific specific TMP 30-50 psi from specific specific 5-15 L/m²/hr from specific specific diafiltration DF: specific specific 5 VVD wash low MW impurities from specific specific dead-end vs. crossflow from specific specific ion exchange: specific specific cation exchange SP Sepharose from specific specific Q anion exchange Sepharose from specific specific protein A affinity IgG from specific specific spray drying: specific specific inlet 180-220°C from specific specific outlet 70-80°C from specific specific D₅₀ 50-200 μm from specific specific water activity a_w <0.3 from specific specific encapsulation: specific specific whey protein microencapsulation from specific specific sodium caseinate wall material from specific specific Maillard glycation from specific specific instantizing lecithination).

What mycoprotein, precision fermentation food formulation, and alternative protein functionality innovations are patentable?

Mycoprotein fungal biomass texture and fiber structure innovations; alternative protein food formulation emulsification gelation and solubility innovations; and novel microbial protein bioavailability digestibility and allergenicity innovations represent additional precision fermentation patent domains: MYCOPROTEIN PATENTS: QUORN/MARLOW FOODS; MEATI FOODS; ATLAST FOOD CO: specific mycoprotein innovations (specific specific Fusarium venenatum Quorn: specific specific aerobic submerged fermentation from specific specific 60 g/L biomass 40% protein dry weight from specific specific 40% dietary fiber β-glucan from specific specific RNA reduction 90°C quenching mandatory EU from specific specific fibrous hyphae texture meat-like from specific specific 50 m³ airlift tower 2.5 m dia from specific specific 24 hr continuous harvest from specific specific Mycoprotein texture: specific specific extrusion high-moisture HME from specific specific twin-screw extruder specific specific 170-180°C SME 150 Wh/kg from specific specific fibrous structure anisotropic from specific specific Meati Foods mycelium: specific specific root-like mycelium biomass from specific specific substrate wheat bran corn flour from specific specific solid-state fermentation from specific specific 48 hr growth 25°C from specific specific mushroom-like flavor compounds from specific specific Atlast FoodTech Emergy Foods: specific specific mycelium bacon-like steak structure from specific specific proprietary SSF substrate); FOOD FORMULATION PATENTS: PERFECT DAY; DSM; INGREDION; ARCHER DANIELS MIDLAND: specific formulation innovations (specific specific whey protein emulsification: specific specific β-LG 18 kDa globular protein from specific specific pH 3.5-5.0 emulsification from specific specific heat-induced gelation 65-80°C from specific specific foam stability drainage half-life 10× vs. soy from specific specific casein micelle: specific specific κ-casein κ-casein from specific specific kappa-casein hairy layer steric stabilization from specific specific micelle size 150-300 nm from specific specific cheese making renneting κ-casein cleavage from specific specific cheesemaking rennet chymosin from specific specific animal-free chymosin DSM MAXIREN: specific specific Kluyveromyces lactis CBS 2360 from specific specific rec rennet from specific specific FDA GRAS 1990 from specific specific 70% global cheese market from specific specific plant protein comparison: specific specific soy protein SPI 90% isolate from specific specific pea protein PEVA 85% from specific specific BLG PDCAAS 1.0 vs. soy 0.98 pea 0.69 from specific specific DIAAS Digestible Indispensable Amino Acid Score BLG 1.09 vs. pea 0.64 from specific specific Maillard reaction: specific specific reducing sugar + amino glycation from specific specific Maillard browning Color Δa* from specific specific advanced glycation end products AGEs); NOVEL PROTEIN INNOVATIONS: BUTTERFLY BIOSCIENCES; CULTIVARIUM; GELTOR: specific novel innovations (specific specific collagen recombinant: specific specific Geltor Streptomyces collagen type I from specific specific procollagen Pichia triple helix from specific specific food grade 10 kDa peptide hydrolysate from specific specific silk protein Bolt Threads Microsilk: specific specific Nephila spider silk gene E. coli from specific specific GPGXX repeat motif from specific specific 100 MPa strength 200% elongation from specific specific egg white protein: specific specific Clara albumin OVA ovalbumin from specific specific 42% protein hen egg white from specific specific Onego Bio chicken ovalbumin Pichia).

What IP strategy should precision fermentation and alternative protein startup founders use?

Precision fermentation startup IP strategy must navigate Perfect Day Trichoderma reesei BLG fermentation patents (200+), Remilk Pichia pastoris BLG patents (100+), Quorn Fusarium venenatum mycoprotein airlift fermentation patents (200+), DSM animal-free rennet chymosin patents (100+), and Ginkgo Bioworks foundry strain engineering patents (500+); understand that Perfect Day holds the first FDA GRAS approval (2020) and broad filamentous fungal BLG expression IP; identify whitespace in novel host organism strains beyond Trichoderma and Pichia (Yarrowia lipolytica, Myceliophthora thermophila for thermostability), novel CRISPR-edited strain for higher titer (>10% by dry weight), novel continuous perfusion bioreactor for lower cost of goods COGS, and novel food-grade encapsulation and stability innovations — while understanding that the alternative protein market is projected to exceed $290B by 2035 and the global fermentation-derived ingredient market is growing 15%/yr driven by FDA GRAS pathway and consumer demand for animal-free ingredients: PRECISION FERMENTATION STARTUP IP STRATEGY: UNDERSTAND THE PRECISION FERMENTATION PATENT LANDSCAPE — PERFECT DAY AND REMILK HOLD BROAD BLG FILAMENTOUS FUNGAL AND YEAST EXPRESSION IP: Perfect Day Trichoderma reesei BLG secretion (GRAS 2020) and Remilk Pichia pastoris BLG AOX1 (GRAS 2022) cover the two dominant production host platforms — new entrants need novel host (Aspergillus, Yarrowia, Myceliophthora), novel protein target (αS1-casein, κ-casein, αS2-lactalbumin, ovalbumin, egg white proteins), or novel downstream purification process; NOVEL STRAIN ENGINEERING FOR >10% TITER AND NOVEL CONTINUOUS PERFUSION PROCESS ARE HIGHEST-VALUE LEAST-CONSOLIDATED IP: After Perfect Day 6% titer (50,000 L fed-batch) and Remilk 100 g/L (150 hr methanol), novel CRISPR protease KO strain >10% dry weight titer, novel methanol-free Pichia promoter, and novel ATF continuous perfusion (10⁷ cells/mL 5 g/L/day) represent less consolidated patent territory; NOVEL MYCOPROTEIN CONTINUOUS AIRLIFT PROCESS BEYOND QUORN IS PATENT-VIABLE: Quorn holds foundational Fusarium venenatum mycoprotein airlift fermentation patents — novel fungal biomass strains (alternative Fusarium, Aspergillus oryzae, Neurospora crassa GRAS), novel substrate (lignocellulosic waste sugar), novel RNA reduction non-thermal (vacuum UV), and novel solid-state fermentation SSF mycelium represent patentable and commercially viable innovations; WHEN TO PATENT IN PRECISION FERMENTATION: NOVEL FERMENTATION PROCESS WITH MEASURED TITER YIELD AND COST OF GOODS: specific novel precision fermentation process (specific specific host organism + specific specific protein target + specific specific fermentation mode fed-batch/perfusion/SSF + specific specific titer g/L + specific specific fermentation time hr + specific specific downstream COGS $/kg protein) vs. specific Perfect Day Trichoderma BLG 6% 24hr 50,000 L or Remilk Pichia BLG 100 g/L 150hr baseline — measured protein titer g/L, fermentation time hr, COGS $/kg, and food-grade purity % vs. Perfect Day or Remilk baseline is the critical precision fermentation IP metric; KEY FTO CHECKLIST: Perfect Day BLG β-LG Trichoderma reesei cbh1 promoter GRAS 2020 6% 50,000 L fed-batch spray dry; Remilk BLG Pichia pastoris GS115 AOX1 methanol 100 g/L 150hr GRAS 2022; Quorn Fusarium venenatum 60 g/L airlift 50m³ 25°C RNA quench 90°C; DSM MAXIREN rennet chymosin K. lactis GRAS 1990 70% market; Ginkgo ATLAS GSMM foundry 15,000 strains/yr; Geltor collagen Streptomyces triple helix food-grade; Onego Bio ovalbumin Pichia; animal-free casein κ-casein renneting micelle.

Related Guides

Synthetic Biology PatentsPlant-Based Protein PatentsGene Therapy PatentsStartup IP Strategy